Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-24

Clinical Trial Update: Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia [Phase 4]

View source ↗

Summary

Phase 4 update on the Stereotaxis system for ablation of persistent ventricular tachycardia, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stereotaxis | Conditions: Ventricular Tachycardia | Phase 4 | Status: COMPLETED | Results posted: 2015-08-24